On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S et al. Acta Haematol. 1995;94(3):128-34. PMID: 7502628 http://www.ncbi.nlm.nih.gov/pubmed/7502628 Like Tweet +1